However, myocilin-associated glaucoma is one of the strongest examples of autosomal dominant inherited Mendelian disease (11, 76, 77), and recent developments in differentiating characteristics of disease variants from benign polymorphisms make myocilin an attractive candidate for precision medicine that targets the underlying disease process. This evidence concerns the gene MYOC and glaucoma.